Care of the COVID-19 exposed complex newborn infant

Abstract

As we confront COVID-19, the global public health emergency of our times, new knowledge is emerging that, combined with information from prior epidemics, can provide insights on how to manage this threat in specific patient populations. Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), both caused by coronaviruses, caused serious respiratory illness in pregnant women that resulted in adverse perinatal outcomes. Thus far, COVID-19 appears to follow a mild course in the vast majority of pregnant women. A significant proportion of pregnant women appear to be asymptomatic carriers of SARS-CoV-2. However, there is limited information on how COVID-19 impacts the fetus and whether vertical transmission occurs. While these knowledge gaps are addressed, it is important to recognize the highly efficient transmission characteristics of SARS-C0V-2 and its potential for causing serious disease in vulnerable individuals, including health care workers. This review provides perspectives from a single center in New York City, the epicenter of the pandemic within the United States. It offers an overview of the preparations required for deliveries of newborns of mothers with COVID-19 and the management of neonates with particular emphasis on those born with complex issues.

COVID 19 in pregnancy; obstetrical and neonatal outcomes: A retrospective comparative study

“…13 By and large there is lack of data on vertical transmission. 14 In present study there was no COVID positive neonate.…”

Nursing care recommendation for pediatric COVID-19 patients in the hospital setting: A brief scoping review

“…A total of 21 papers describe the regulation of contact between infants and mothers who are infected with COVID-19 or at risk of COVID-19. The types of interventions recommended by previous authors include avoiding skin-to-skin contact [ 56 , 138 – 142 ], isolation of infants in negative pressure incubators [ 60 , 67 , 111 , 143 , 144 ] or isolation separately from the mother for 14 days [ 55 , 77 , 111 , 120 , 138 , 140 ], rooming-in provision [ 61 , 68 , 147 ], and wear a face mask when breastfeeding or in close contact with infants [ 55 – 59 , 62 , 143 ].…”

The effect of COVID-19 on maternal and neonatal outcome - A retrospective study

“…There was no evidence of vertical transmission of SARS-COV-2 from mother to fetus via placenta or caesarean section delivery or vaginal delivery in this study similar to other studies reported. 13,14 None of the literature has detected virus in cord blood, placenta or breast milk. 14 Till date no complication related to steroid use have been reported in mother or infant, but their safety still needs more data to draw conclusion.…”

“…13,14 None of the literature has detected virus in cord blood, placenta or breast milk. 14 Till date no complication related to steroid use have been reported in mother or infant, but their safety still needs more data to draw conclusion.…”